Holen Sie sich die Stockscreener-App
14.97
1.39%
0.21
Finanzdaten der Keros Therapeutics Inc-Aktie (KROS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
91.40%
18.17
|
211.19 | 3.042 | 0.388 | 0.037 |
Operating Expenses
|
2.06%
57.98
|
59.21 | 56.30 | 59.05 | 50.48 |
| Benefits Costs and Expenses |
3.06%
51.09
|
52.70 | 190.60 | - | - |
| Costs And Expenses |
3.06%
51.09
|
52.70 | 32.52 | 59.05 | 50.48 |
| Operating Income/Loss |
126.19%
-39.82
|
152.04 | -53.25 | -58.66 | -50.44 |
| Nonoperating Income/Loss |
6.89%
6.899
|
6.454 | 7.528 | 5.701 | 5.182 |
| Income/Loss From Continuing Operations Before Tax |
120.77%
-32.92
|
158.49 | -187.56 | 0.388 | -45.26 |
| Income Tax Expense/Benefit |
122.12%
-2.222
|
10.04 | - | - | - |
| Income/Loss From Continuing Operations After Tax |
120.68%
-30.70
|
148.45 | -46.03 | -52.96 | -45.26 |
|
Net Income/Loss
|
120.68%
-30.70
|
148.45 | -46.03 | -52.96 | -45.26 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.13%
40.61
|
40.56 | 0.9737 | 37.59 | 36.10 |
| Diluted Average Shares |
1.00%
40.61
|
41.02 | 0.9737 | 37.59 | 36.10 |
| Basic Earnings Per Share |
120.77%
-0.76
|
3.66 | -1.12 | -1.41 | -1.25 |
| Diluted Earnings Per Share |
120.99%
-0.76
|
3.62 | -1.12 | -1.41 | -1.25 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.49%
1.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):